Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

ICU-treated influenza A(H1N1) pdm09 infections more severe post pandemic than during 2009 pandemic: a retrospective analysis

Authors: Pekka Ylipalosaari, Tero I. Ala-Kokko, Jouko Laurila, Lauri Ahvenjärvi, Hannu Syrjälä

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

We compared in a single mixed intensive care unit (ICU) patients with influenza A(H1N1) pdm09 between pandemic and postpandemic periods.

Methods

Retrospective analysis of prospectively collected data in 2009–2016. Data are expressed as median (25th–75th percentile) or number (percentile).

Results

Seventy-six influenza A(H1N1) pdm09 patients were admitted to the ICU: 16 during the pandemic period and 60 during the postpandemic period. Postpandemic patients were significantly older (60 years vs. 43 years, p < 0.001) and less likely to have epilepsy or other neurological diseases compared with pandemic patients (5 [8.3%] vs. 6 [38%], respectively; p = 0.009). Postpandemic patients were more likely than pandemic patients to have cardiovascular disease (24 [40%] vs. 1 [6%], respectively; p = 0.015), and they had higher scores on APACHE II (17 [13–22] vs. 14 [10–17], p = 0.002) and SAPS II (40 [31–51] vs. 31 [25–35], p = 0.002) upon admission to the ICU. Postpandemic patients had higher maximal SOFA score (9 [5–12] vs. 5 [4–9], respectively; p = 0.03) during their ICU stay. Postpandemic patients had more often septic shock (40 [66.7%] vs. 8 [50.0%], p = 0.042), and longer median hospital stays (15.0 vs. 8.0 days, respectively; p = 0.006). During 2015–2016, only 18% of the ICU- treated patients had received seasonal influenza vaccination.

Conclusions

Postpandemic ICU-treated A(H1N1) pdm09 influenza patients were older and developed more often septic shock and had longer hospital stays than influenza patients during the 2009 pandemic.
Literature
1.
go back to reference Ørsted A, Mølvadgaard M, Nielsen HL, Nielsen H. The first, second and third wave of pandemic influenza a (H1N1)pdm09 in North Denmark region 2009–2011: a population-based study of hospitalizations. Influenza Other Resp Viruses. 2013;7:776. 10.1111/irv.12093 CrossRef Ørsted A, Mølvadgaard M, Nielsen HL, Nielsen H. The first, second and third wave of pandemic influenza a (H1N1)pdm09 in North Denmark region 2009–2011: a population-based study of hospitalizations. Influenza Other Resp Viruses. 2013;7:776. 10.​1111/​irv.​12093 CrossRef
2.
go back to reference Viasus D, Cordero E, Rodríguez-Baño J, Oteo JA, Fernández-Navarro A, Ortega L, et al. Changes in epidemiology, clinical features and severity of influenza a (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Inf. 2012;18:E55–62.CrossRef Viasus D, Cordero E, Rodríguez-Baño J, Oteo JA, Fernández-Navarro A, Ortega L, et al. Changes in epidemiology, clinical features and severity of influenza a (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Inf. 2012;18:E55–62.CrossRef
3.
go back to reference Jhung MA, Swerdlow D, Olsen SJ, Jernigan D, Biggerstaff M, Kamimoto L, et al. Epidemiology of 2009 pandemic influenza a (H1N1) in the United States. Clin Inf Dis. 2011;52:S13–26.CrossRef Jhung MA, Swerdlow D, Olsen SJ, Jernigan D, Biggerstaff M, Kamimoto L, et al. Epidemiology of 2009 pandemic influenza a (H1N1) in the United States. Clin Inf Dis. 2011;52:S13–26.CrossRef
4.
go back to reference Mertz D, Kim TH, Johnstone J, Lam P, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061.CrossRefPubMedPubMedCentral Mertz D, Kim TH, Johnstone J, Lam P, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061.CrossRefPubMedPubMedCentral
6.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.CrossRefPubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.CrossRefPubMed
7.
go back to reference Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter S, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med. 1998;26:1793–800.CrossRefPubMed Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter S, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med. 1998;26:1793–800.CrossRefPubMed
8.
go back to reference Le Gall J, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA. 1993;270:2957–63.CrossRefPubMed Le Gall J, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA. 1993;270:2957–63.CrossRefPubMed
10.
go back to reference Mishel P, Ojala T, Benner C. Comparative analysis of whole-genome sequences of influenza a(H1N1)pdm09 viruses isolated from hospitalized and nonhospitalized patients identifies Missense mutations that might be associated with patient hospital admissions in Finland during 2009 to 2014. Genome Announcements. 2015;3(4):e00676-15. 10.1128/genomeA.00676-15.CrossRefPubMedPubMedCentral Mishel P, Ojala T, Benner C. Comparative analysis of whole-genome sequences of influenza a(H1N1)pdm09 viruses isolated from hospitalized and nonhospitalized patients identifies Missense mutations that might be associated with patient hospital admissions in Finland during 2009 to 2014. Genome Announcements. 2015;3(4):e00676-15. 10.​1128/​genomeA.​00676-15.CrossRefPubMedPubMedCentral
11.
go back to reference Elderfield RA, Watson SJ, Godlee A, Adamson WE, Thompson CI, Dunning J, et al. Accumulation of human-adapting mutations during circulation of a(H1N1)pdm09 influenza virus in humans in the United Kingdom. J Virology. 2014;88:13269–83.CrossRefPubMedPubMedCentral Elderfield RA, Watson SJ, Godlee A, Adamson WE, Thompson CI, Dunning J, et al. Accumulation of human-adapting mutations during circulation of a(H1N1)pdm09 influenza virus in humans in the United Kingdom. J Virology. 2014;88:13269–83.CrossRefPubMedPubMedCentral
12.
go back to reference DiazGranados CA, Dunning AJ, Robertson CA, Talbot HK, Landolfi V, Greenberg DP. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty. Vaccine. 2015;33:4565–71.CrossRefPubMed DiazGranados CA, Dunning AJ, Robertson CA, Talbot HK, Landolfi V, Greenberg DP. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty. Vaccine. 2015;33:4565–71.CrossRefPubMed
13.
go back to reference Pilkinton MA, Nicholas KJ, Warren CM, Smith RM, Yoder SM, Talbot HK, et al. Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion. Vaccine. 2017;35:329–36.CrossRefPubMed Pilkinton MA, Nicholas KJ, Warren CM, Smith RM, Yoder SM, Talbot HK, et al. Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion. Vaccine. 2017;35:329–36.CrossRefPubMed
14.
go back to reference Izurieta P, Kim WJ, Wie S, Lee J, Lee J, Dramé M, et al. Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: a phase IV, randomized, open-label, controlled study. Vaccine. 2015;33:2800–7.CrossRefPubMed Izurieta P, Kim WJ, Wie S, Lee J, Lee J, Dramé M, et al. Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: a phase IV, randomized, open-label, controlled study. Vaccine. 2015;33:2800–7.CrossRefPubMed
15.
go back to reference Minchole E, Figueredo AL, Omeñaca M, Panadero C, Royo L. Seasonal influenza a H1N1pdm09 virus and severe outcomes: a reason for broader vaccination in non-elderly, at-risk people. PLoS One. 2016;11(11):e0165711.CrossRefPubMedPubMedCentral Minchole E, Figueredo AL, Omeñaca M, Panadero C, Royo L. Seasonal influenza a H1N1pdm09 virus and severe outcomes: a reason for broader vaccination in non-elderly, at-risk people. PLoS One. 2016;11(11):e0165711.CrossRefPubMedPubMedCentral
16.
go back to reference Casado I, Domínguez A, Toledo D, Chamorro J, Force L, Soldevila N, et al. Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Exp Rev Vaccines. 2016;15:425–32. Casado I, Domínguez A, Toledo D, Chamorro J, Force L, Soldevila N, et al. Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Exp Rev Vaccines. 2016;15:425–32.
17.
go back to reference Ayscue P, Murray E, Uyeki T, Zipprich J, Harriman K, Salibay C. Influuenza-Associated Intensive-Care Unit Admissions and Deaths-California, September 29, 2013–January 1, 2014 February 21, 2014. Morb Mortal Wkly Rep. 2014;63(07);143–7. Ayscue P, Murray E, Uyeki T, Zipprich J, Harriman K, Salibay C. Influuenza-Associated Intensive-Care Unit Admissions and Deaths-California, September 29, 2013–January 1, 2014 February 21, 2014. Morb Mortal Wkly Rep. 2014;63(07);143–7.
18.
go back to reference Shah NS, Greenberg JA, McNulty MC. Severe Influenza in 33 US Hospitals, 2013–2014: Complications and Risk Factors for Death in 507 Patients. Infect Control Hosp Epidemiol. 2015;1251–60. Shah NS, Greenberg JA, McNulty MC. Severe Influenza in 33 US Hospitals, 2013–2014: Complications and Risk Factors for Death in 507 Patients. Infect Control Hosp Epidemiol. 2015;1251–60.
19.
go back to reference Arriola CS, Anderson EJ, Baumbach J, Bennett N, Bohm S, Hill M, et al. Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States. J Inf Dis. 2015;212:1200–8.CrossRef Arriola CS, Anderson EJ, Baumbach J, Bennett N, Bohm S, Hill M, et al. Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States. J Inf Dis. 2015;212:1200–8.CrossRef
20.
go back to reference Bramley AM, Dasgupta S, Skarbinski J, Kamimoto L, Fry AM, Finelli L, Jain S. 2009 pandemic influenza a (H1N1) virus hospitalizations investigation team. Intensive care unit patients with 2009 pandemic influenza a (H1N1pdm09) virus infection - United States, 2009. Influenza Other Respir Viruses. 2012;6(6):e134–42. 10.1111/j.1750-2659.2012.00385.x. Epub 2012 Jun 6CrossRefPubMedPubMedCentral Bramley AM, Dasgupta S, Skarbinski J, Kamimoto L, Fry AM, Finelli L, Jain S. 2009 pandemic influenza a (H1N1) virus hospitalizations investigation team. Intensive care unit patients with 2009 pandemic influenza a (H1N1pdm09) virus infection - United States, 2009. Influenza Other Respir Viruses. 2012;6(6):e134–42. 10.1111/j.1750-2659.2012.00385.x. Epub 2012 Jun 6CrossRefPubMedPubMedCentral
21.
go back to reference Nermin KG, Remzi I, Zeynep A. A retrospective evaluation of critically ill patients infected with H1N1 influenza a virus in Bursa, Turkey, during the 2009–2010 pandemic. Afr Health Sci. 2015;15:352–9.CrossRefPubMedPubMedCentral Nermin KG, Remzi I, Zeynep A. A retrospective evaluation of critically ill patients infected with H1N1 influenza a virus in Bursa, Turkey, during the 2009–2010 pandemic. Afr Health Sci. 2015;15:352–9.CrossRefPubMedPubMedCentral
22.
go back to reference Jefferson T, Jones M, Doshi P, Del Mar CP, Hama R, Thompson M. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4–558. Jefferson T, Jones M, Doshi P, Del Mar CP, Hama R, Thompson M. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4–558.
23.
go back to reference Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Mamun AA, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an IPD meta-analysis. Influenza Other Respir Viruses. 2016;10(3):192–204. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Mamun AA, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an IPD meta-analysis. Influenza Other Respir Viruses. 2016;10(3):192–204.
Metadata
Title
ICU-treated influenza A(H1N1) pdm09 infections more severe post pandemic than during 2009 pandemic: a retrospective analysis
Authors
Pekka Ylipalosaari
Tero I. Ala-Kokko
Jouko Laurila
Lauri Ahvenjärvi
Hannu Syrjälä
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2829-3

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.